GRI Bio, Inc.
GRI
$1.46
-$0.05-3.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.95M | -2.12M | -2.25M | -1.89M | -2.00M |
| Total Depreciation and Amortization | -103.00K | 1.00K | -13.00K | 15.00K | -38.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 203.00K | 47.00K | -91.00K | 35.00K | -111.00K |
| Change in Net Operating Assets | -101.00K | -194.00K | 213.00K | -366.00K | -3.41M |
| Cash from Operations | -2.00M | -2.27M | -2.14M | -2.20M | -5.56M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 2.38M | 1.03M | 4.96M | 5.50M | 0.00 |
| Repurchase of Common Stock | 0.00 | -1.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -96.00K | -366.00K | -557.00K | -1.01M | 3.88M |
| Cash from Financing | 2.28M | 661.00K | 4.40M | 4.49M | 3.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 282.00K | -1.61M | 2.26M | 2.28M | -1.68M |